HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Polymorphisms in the PTX1 may not be associated with ischemic stroke susceptibility.

AbstractOBJECTIVE:
Ischemic stroke is a global health burden due to the increasingly higher incidence rate and mortality rate. Etiological research into the role of genetics in this heterogeneous disease may have diagnostic and prognostic implications. The present study was designed to assess the association between PTX1 SNPs: -717A>G and -286C>T>A, and ischemic stroke risk.
METHODS:
Risk of ischemic stroke was estimated using summary ORs. The fixed effects model was performed in calculating the pooled ORs. All statistical data were analyzed with STATA software.
RESULTS:
We combined 4,604 subjects for SNP -717A>G and 3,093 subjects for SNP -286C>T>A. SNP -717A>G was not found to be significantly associated with ischemic stroke risk (GG vs. AA, OR = 1.12, 95% CI = 0.83-1.50, PHet = 0.207; GG + GA vs. AA, OR = 1.04, 95% CI = 0.93-1.17, PHet = 0.533; GG vs. GA + AA, OR = 1.10, 95% CI = 0.82-1.47, PHet = 0.220). Meta-analysis of SNP -286C>T>A also demonstrated no statistical evidence of a significant association with ischemic stroke (AA vs. CC, OR = 0.86, 95% CI = 0.59-1.25, PHet = 0.348; AA vs. CC, OR = 0.92, 95% CI = 0.80-1.06, PHet = 0.609; AA vs. CC, OR = 0.89, 95% CI = 0.62-1.30, PHet = 0.374).
CONCLUSIONS:
These results suggest that the PTX1 gene polymorphisms may not be associated with a predisposition to ischemic stroke.
AuthorsHeyin Mi, Wenli Hu
JournalInternational journal of clinical and experimental medicine (Int J Clin Exp Med) Vol. 7 Issue 11 Pg. 3992-9 ( 2014) ISSN: 1940-5901 [Print] United States
PMID25550907 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: